- Report
- August 2025
- 281 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 452 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 470 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 380 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 282 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 367 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 488 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 486 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 388 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 387 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 380 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 281 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 469 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 287 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 359 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 368 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 369 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 486 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 276 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 473 Pages
Global
From €5208EUR$5,850USD£4,501GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more